ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
Public ClinicalTrials.gov record NCT01098435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Study identification
- NCT ID
- NCT01098435
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Alkermes, Inc.
- Industry
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Interventions
- RDC-0313 (ALKS 33) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2010
- Primary completion
- Apr 30, 2011
- Completion
- May 31, 2011
- Last update posted
- Aug 22, 2011
2010 – 2011
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes' Investigational Study Site | Tucson | Arizona | 85712 | — |
| Alkermes' Investigational Study Site | Minneapolis | Minnesota | 55454 | — |
| Alkermes' Investigational Study Site | Manlius | New York | 13104 | — |
| Alkermes' Investigational Study Site | Raleigh | North Carolina | 27612 | — |
| Alkermes' Investigational Study Site | Mason | Ohio | 45040 | — |
| Alkermes' Investigational Study Site | Toledo | Ohio | 43623 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01098435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2011 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01098435 live on ClinicalTrials.gov.